Literature DB >> 22843896

Role of androgen excess in the development of estrogen receptor-positive and estrogen receptor-negative breast cancer.

Giorgio Secreto1, Barnett Zumoff.   

Abstract

The androgen-excess theory posits a central role of androgens in promoting breast cancer development. At first glance, this appears to contradict the currently accepted central role of estrogens in this process, but as we will show, the apparent contradiction is not a real one. In the present article, we review the mechanisms by which androgen excess may stimulate cancer growth in different subsets of estrogen receptor-positive and estrogen receptor-negative tumors. We also propose an endocrine classification of postmenopausal breast cancer based on the simultaneous evaluation of a patient's serum testosterone levels and the estrogen receptor status of the tumor. This classification identifies several different subsets of tumors and may have important clinical implications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22843896

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Importance of revealing a rare case of breast cancer in a female to male transsexual after bilateral mastectomy.

Authors:  Dejan V Nikolic; Miroslav L Djordjevic; Miroslav Granic; Aleksandra T Nikolic; Violeta V Stanimirovic; Darko Zdravkovic; Svetlana Jelic
Journal:  World J Surg Oncol       Date:  2012-12-28       Impact factor: 2.754

2.  Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options.

Authors:  Pierluigi Gasparini; Matteo Fassan; Luciano Cascione; Gulnur Guler; Serdar Balci; Cigdem Irkkan; Carolyn Paisie; Francesca Lovat; Carl Morrison; Jianying Zhang; Aldo Scarpa; Carlo M Croce; Charles L Shapiro; Kay Huebner
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

3.  Breast Cancer in the Transgender Population.

Authors:  Andrea Fehl; Shannon Ferrari; Zoe Wecht; Margaret Rosenzweig
Journal:  J Adv Pract Oncol       Date:  2019-03-01

Review 4.  The Other Side of the Coin: May Androgens Have a Role in Breast Cancer Risk?

Authors:  Chiara Chiodo; Catia Morelli; Fabiola Cavaliere; Diego Sisci; Marilena Lanzino
Journal:  Int J Mol Sci       Date:  2021-12-31       Impact factor: 5.923

5.  Occult leydig cell tumour and androgen-receptor positive breast cancer in a woman with severe hyperandrogenism.

Authors:  Giovanna Saraceno; Valeria Barresi; Francesco Trimarchi; Salvatore Cannavo
Journal:  J Ovarian Res       Date:  2013-07-01       Impact factor: 4.234

6.  Breast malignancy in female-to-male transsexuals: systematic review, case report, and recommendations for screening.

Authors:  Anne C Fledderus; H Antoine Gout; Aernout C Ogilvie; Dorothea K G van Loenen
Journal:  Breast       Date:  2020-07-02       Impact factor: 4.380

7.  Pre-Menopausal Women With Breast Cancers Having High AR/ER Ratios in the Context of Higher Circulating Testosterone Tend to Have Poorer Outcomes.

Authors:  Savitha Rajarajan; Aruna Korlimarla; Annie Alexander; C E Anupama; Rakesh Ramesh; B S Srinath; T S Sridhar; Jyothi S Prabhu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-21       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.